NAS:IDXX (USA) Also trade in: Austria Germany UK

IDEXX Laboratories Inc

$ 271.09 1.37 (0.51%)
Volume: 41,988 Avg Vol (1m): 441,379
Market Cap $: 23.16 Bil Enterprise Value $: 24.09 Bil
P/E (TTM): 60.78 P/B: 457.17
Earnings Power Value 29.04
Net Current Asset Value -10.64
Tangible Book -2.31
Projected FCF 37.97
Median P/S Value 107.85
Graham Number 0
Peter Lynch Value 82.13
DCF (FCF Based) 76.03
DCF (Earnings Based) 88.29
1Y (-%)

GuruFocus Articles Total 72
  • 1
  • 2
  • 3
  • 4

By Portfolio Manager Neal Rosenberg: How the 'humanization' of pets has created a booming industry

Key Points

  1. The pet industry is experiencing significant and sustainable growth
  2. Pet owners increasingly view pets as members of their family and are willing to spend accordingly; demographics suggest this will continue
  3. The animal health industry is structurally more attractive than the human health industry due to superior growth, less regulation, less costly R&D projects, and lack of third party payers
  4. We believe IDEXX (diagnostics), Dechra (veterinary pharmaceuticals), and Covetrus (veterinary technology) are excellent investment opportunities in the animal health space

According to the American Pet Products Association, Americans are spending more on pets than ever before: $73

143 Views    Holly LaFon    2019-05-21 18:55
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) increased after the company reported robust financial results. In the core companion animal business, competitive trends are outstanding, highlighted by instrument installed base growth of 21%, domestic lab growth more than twice that of competitor VCA, and improving sales productivity. We think new proprietary innovations and field sales force expansion should be meaningful contributors to growth. Margins are moving significantly higher, and we believe they can approach 30% over the next several years.



From [url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Ron Baron[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=Ron+Baron]Portfolio[/url])'s Baron

51 Views    Holly LaFon    2019-04-29 19:41
Dallas-based vehicle auctioneer tops list of stalwarts in terms of operating margin

According to the All-in-One Screener, five Peter Lynch stalwarts with strong profit margins are Copart Inc. (CPRT), Intel Corp. (INTC), Edwards Lifesciences Corp. (EW), Masimo Corp. (MASI) and IDEXX Laboratories Inc. (IDXX).

Starting point: Peter Lynch Stalwarts screen

According to Investopedia, Lynch defined a stalwart as “a large, well-established company that still offers long-term growth potential.” The investor sought companies with a strong balance sheet, little or no debt, solid cash flow and earnings growth between 10% and 12%.

GuruFocus launched a new version of the All-in-One Screener

774 Views    James Li    2019-04-26 20:47

NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (IDXX), Aegion Corporation (AEGN), NetScout Systems, Inc. (NTCT), Castlight Health, inc. (:CSLT), Leap Therapeutics, Inc. (LPTX), and Speedway Motorsports, Inc. (:TRK), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2019-04-12 12:01
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) detracted from performance. While financial results were strong, unfavorable weather in Europe and depressed global milk prices temporarily reduced reported growth. We estimate that just 1% to 2% of IDEXX’s profit is exposed to milk prices, and we believe that weather trends in Europe have normalized. We believe that competitive trends are outstanding in IDEXX’s core companion animal business, highlighted by instrument installed base growth of 20%, domestic lab growth more than twice that of its main competitor, and improving sales productivity. We expect new proprietary innovations and ongoing sales

59 Views    Holly LaFon    2019-01-24 20:39
Discussion of markets and holdings

Dear Baron Growth Fund Shareholder:

Performance

Markets declined significantly during the quarter, erasing all the gains that had been generated through September. Baron Growth Fund (the “Fund”) declined 18.53% (Institutional Shares), but exceeded the performance of its benchmark, the Russell 2000 Growth Index, which declined 21.65%. For the year, the Fund declined 2.67%, which exceeded the performance of its benchmark by 6.64%. Almost half of the Fund’s relative outperformance occurred during the fourth quarter, when our strategy of investing in high-quality businesses with consistent and visible revenue and earnings growth proved valuable during a time of market volatility. For the

226 Views    Holly LaFon    2019-01-24 19:35

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of First Data Corporation (:FDC), IDEXX Laboratories, Inc. (IDXX), CMS Energy Corporation (:CMS), Worthington Industries, Inc. (:WOR), Triumph Group, Inc. (:TGI), and Cara Therapeutics, Inc. (CARA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the

0 Views    Marketwired    2019-01-24 17:01
PM Lauren Romeo discusses finding opportunities in the recent downturn and what she likes about four current holdings

What is your take on the recent market downturn?

Downturns are never pleasant in the short run. However, at Royce we always try to put cash to work when share prices are falling to create potentially rewarding long-term opportunities.

The kind of high-quality characteristics that we seek in Premier—companies with high returns on invested capital and sustainable competitive advantages—are usually trading more closely to their full valuation. It can take a long time for what we think are high-quality small-caps to enter a favorable valuation range.

So far in the fourth quarter, we’ve added four new names to Premier’s

66 Views    Holly LaFon    2018-12-11 20:44

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (IDXX), Editas Medicine, Inc. (EDIT), Arconic Inc. (:ARNC), Cardtronics PLC (CATM), Cloudera, Inc. (:CLDR), and BMC Stock Holdings, Inc. (BMCH), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

0 Views    Marketwired    2018-11-12 17:02
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) contributed to performance, buoyed by continued strong competitive trends, highlighted by instrument installed base growth of 20%, domestic lab growth more than twice that of competitor VCA, and improving sales productivity. We think new proprietary innovations and field sales force expansion should be meaningful contributors to growth. Margins are moving significantly higher, and we believe they can approach 30% over the next several years.

From [url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Ron Baron[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=Ron+Baron]Portfolio[/url])'s third-quarter Baron Partners Fund shareholder letter.

38 Views    Holly LaFon    2018-11-02 18:44
Discussion of markets and holdings

Dear Baron Partners Fund Shareholder:

Performance

Baron Partners Fund (the “Fund”) gained 2.14% (Institutional Shares) during the three-month period ended September 30, 2018. This was less than the Russell Midcap Growth Index, its benchmark, which appreciated 7.57%, and the S&P 500 Index, which gained 7.71%. For the nine months year-to-date, Baron Partners Fund gained 17.98%. The Russell Midcap Growth Index gained 13.38% and the S&P 500 Index increased 10.56%.

The Fund’s relative underperformance in the last three months was despite strong results for 47.76% of the Fund’s average portfolio weights based on the Fund’s net assets. That portfolio segment achieved

240 Views    Holly LaFon    2018-10-30 19:44

NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Altra Industrial Motion Corp. (AIMC), IDEXX Laboratories, Inc. (IDXX), BioTelemetry, Inc. (BEAT), Galectin Therapeutics Inc. (GALT), NETGEAR, Inc. (NTGR), and Merck & Co., Inc. (:MRK), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2018-10-11 12:00
As of late, multiple companies have all managed to achieve yearly highs

According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs.

IDEXX Laboratories Inc. (IDXX) reached the 52-week high of $225.53

IDEXX Laboratories Inc. develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets. IDEXX Laboratories Inc. primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, laboratory equipment for blood-panel analysis, reference lab services, and tests to detect

40 Views    yifan900    2018-07-10 15:10

NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cara Therapeutics, Inc. (CARA), MGE Energy Inc. (MGEE), IDEXX Laboratories, Inc. (IDXX), Sterling Construction Company Inc (STRL), TTM Technologies, Inc. (TTMI), and Regis Corporation (:RGS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the

0 Views    Marketwired    2018-04-30 16:04
An oilfield services company is the guru’s largest new position

Spiros Segalas (Trades, Portfolio), portfolio manager of the Harbor Capital Appreciation Fund, released his first-quarter portfolio on Tuesday, disclosing he established five new positions.

With the goal of investment growth, the fund invests in companies with strong balance sheets and earnings performance, a strong outlook for sales growth, a history of high profitability and good management.

In the first quarter, the guru purchased Schlumberger Ltd. (SLB), Walmart Inc. (WMT), PNC Financial Services Group Inc. (PNC), Square Inc. (SQ) and IDEXX Laboratories Inc. (IDXX).

Schlumberger

Having previously exited a position in Schlumberger in the second quarter of 2017,

319 Views    Sydnee Gatewood    2018-04-04 16:31
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) rose in the first quarter, rallying on strong financial results and multiple expansion. Competitive trends are strong and improving, highlighted by instrument revenue growth, domestic lab growth, rising sales productivity, and stability in rapid assays. We think that IDEXX’s direct go-to-market model coupled with meaningful research and development-driven product enhancements will put steady upward pressure on organic revenue and earnings growth over time. (Neal Rosenberg)

From [url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Ron Baron[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=Ron+Baron]Portfolio[/url])'s first quarter 2017 Baron Partners Fund commentary.

142 Views    Holly LaFon    2017-04-25 16:21
Stocks achieve yearly milestone

According to GuruFocus, these stocks have reached their 52-week highs.

Mastercard reached the 52-week high of $112.47

Mastercard Inc. (MA) is a technology company in the payments industry that connects consumers, financial institutions, merchants, governments and businesses, enabling them to use electronic forms of payment instead of cash and checks. Mastercard manages several payment brands and an "open loop" global payment network, which allows it to provide authorization, clearing and settlement of electronic payment transactions. The company generates revenue by charging fees to its customers (issuers and acquirers) based on both the dollar volume of card activity and

83 Views    yifan900    2017-04-04 16:55
First Trust Water has beaten the S&P 500 for the past decade

According to financial research provider Morningstar, over the past 10 years, the S&P 500 has produced an average annual total return for investors of 5% per annum. Over the same period, the First Trust Water (FIW) exchange-traded fund has produced an average annualized return of 8%, outperforming the wider market by 3% per annum with an annual expense ratio of 0.57%. Granted, the First Trust Water ETF was not launched until May 2007, so these figures are out by a few months. Nonetheless, they do present a clear picture.

An ETF to beat the market

The First Trust

121 Views    Rupert Hargreaves    2017-02-23 22:52
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) increased in the third quarter. The stock continued to rally on strong financial results and multiple expansion. Competitive trends are strong and improving, highlighted by instrument revenue growth, domestic lab growth, rising sales productivity, and stability in rapid assays. We believe that IDEXX’s direct go-to-market model coupled with research and development-driven product enhancements will put steady upward pressure on organic revenue and earnings growth over time. (Neal Rosenberg)

From [url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Ron Baron[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=Ron+Baron]Portfolio[/url])'s Barons Partners Fund third-quarter 2016 commentary.

521 Views    Holly LaFon    2016-11-14 17:29
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) increased after the company reported impressive financial results, which led to a meaningful expansion in its trading multiple. We believe the company’s competitive position is strong and improving, as evidenced by its accelerating organic revenue growth, the robust placements of its diagnostic instruments into veterinary clinics, and the higher prices it is capturing across its product portfolio. In addition, IDEXX’s results demonstrated operating margin expansion, which is finally being recognized after several years of intensive investment into its business. Looking forward, we expect to witness sustained double-digit organic revenue growth

379 Views    Holly LaFon    2016-10-21 19:12

Headlines Total 251
  • 1
  • 2
  • 3

2019-06-14 $267.74 (0.22%)
6:24am
2019-06-07 $264.92 (2.02%)
6:52am
2019-05-31 $249.77 (0.03%)
8:31am
2019-05-29 $247.45 (0.24%)
7:32am
2019-05-07 $245.45 (-2.55%)
12:39pm
2019-05-06 $251.88 (0.56%)
5:12am
2019-05-02 $242.34 (3.54%)
8:27pm
1:28am
2019-05-01 $234.06 (0.89%)
4:19pm
3:43pm
12:16pm
10:39am
2019-04-30 $232 (0.57%)
9:04am
2019-04-29 $230.68 (-0.77%)
2:41pm
2019-04-24 $224.58 (0.06%)
9:33am
2019-03-28 $220.56 (0.79%)
10:02am
2019-03-27 $218.84 (-0.53%)
6:59am
2019-03-20 $219.27 (0.44%)
10:48am
2019-03-19 $218.3 (1.19%)
9:56am
8:35am
2019-03-18 $215.74 (-0.22%)
10:17am
2019-03-15 $216.21 (2.53%)
2:26pm
2019-03-14 $210.87 (0.47%)
2:32pm
2019-03-13 $209.89 (1.9%)
11:41am
8:58am
2019-03-12 $205.97 (0.61%)
10:27am
2019-03-08 $201.74 (-1.05%)
8:10am
2019-03-07 $203.89 (-1.89%)
7:33am
2019-03-05 $210.8 (-1.22%)
8:50am
2019-02-13 $210.39 (0.42%)
9:00am
2019-02-12 $209.5 (1.38%)
7:39am
2019-02-07 $206.81 (-0.97%)
3:43pm
2019-02-06 $208.83 (0.41%)
8:11pm
2019-02-01 $205.38 (-3.48%)
1:19pm
12:45pm
6:50am
2019-01-31 $212.78 (2.46%)
9:54am
2019-01-29 $204.29 (-0.69%)
8:30pm
2019-01-28 $205.7 (-1.51%)
8:48am
2019-01-25 $208.85 (1.3%)
9:30am
2019-01-24 $206.16 (2.24%)
2:39pm
1:35pm
2019-01-14 $189.79 (-1.62%)
9:15pm
2018-12-01
8:31am
2018-11-16 $201.37 (0.4%)
12:34pm
2018-11-12 $198.82 (-4.03%)
6:18pm
11:02am
2018-11-09 $207.17 (-1.19%)
6:46am
2018-11-08 $209.67 (-0.06%)
8:08pm
2018-11-02 $204.91 (-0.07%)
1:44pm
2018-11-01 $205.06 (-3.33%)
3:45pm
9:37am
2018-10-25 $210.78 (1.85%)
11:27am
9:34am
2018-10-23 $218.12 (-0.76%)
9:10am
2018-10-17 $228.49 (1.2%)
7:36am
2018-10-12 $222.42 (3.88%)
8:42am
7:41am
2018-09-28 $249.66 (0.39%)
1:06pm
2018-09-26 $244.39 (-0.59%)
10:30am
2018-09-25 $245.84 (1.29%)
7:40am
2018-09-18 $245.22 (0.94%)
7:07am
2018-09-17 $242.94 (-2.02%)
8:11pm
2018-09-13 $249.29 (1.48%)
8:23am
2018-09-10 $246.11 (1.47%)
7:12am
2018-09-01
12:05am
2018-08-30 $253.48 (-0.39%)
7:44am
2018-08-28 $251.7 (0.14%)
9:40am
2018-08-23 $245.97 (0.03%)
7:38am
2018-08-22 $245.89 (1.39%)
2:34am
2018-08-21 $242.52 (0.02%)
11:51am
2018-08-16 $243.26 (0.7%)
1:53pm
7:39am
6:42am
2018-08-09 $244.63 (-0.65%)
7:41am
2018-08-08 $246.22 (0.29%)
7:02pm
1:32pm
2018-08-07 $245.52 (1.07%)
8:35am
2018-08-03 $242.64 (0.76%)
3:15pm
2018-08-01 $236.15 (-3.58%)
2:50pm
12:53pm
7:33am
7:16am
7:12am
2018-07-31 $244.93 (3.02%)
8:01pm
2018-07-24 $248.07 (-0.19%)
6:47pm
2018-07-23 $248.55 (0.17%)
10:22am
2018-07-13 $238.15 (0.29%)
6:56am
2018-07-10 $234.1 (2%)
10:10am
2018-07-05 $221.84 (1.38%)
2:41pm
2018-06-26 $217.34 (-0.07%)
8:37am
2018-06-25 $217.49 (-2.43%)
10:43am
8:30am
2018-06-20 $224.98 (-0.18%)
7:24am
2018-06-15 $227.9 (0.81%)
9:39am
7:49am
2018-06-13 $222.58 (0.11%)
1:34pm
2018-06-07 $218.04 (-0.67%)
10:07am
2018-06-04 $218.81 (1.6%)
3:55am
2018-05-31 $208.21 (-0.42%)
7:36am
Total 251
  • 1
  • 2
  • 3